Focus on triamcinolone acetonide as an adjunct to glaucoma filtration surgery

Medical Hypotheses

Volumn 68, Issue 2, 2007, Pages 401-403

  Hosseini, Hamid ^a   Mehryar, Morsal ^a   Farvardin, Mohsen ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBROTIC AGENT; CORTICOSTEROID; FLUOROURACIL; MITOMYCIN C; STEROID; TRIAMCINOLONE ACETONIDE;

ADD ON THERAPY; ARTICLE; FILTERING OPERATION; FOLLOW UP; GLAUCOMA; GLAUCOMA SURGERY; HUMAN; PRIORITY JOURNAL; TRABECULECTOMY; TREATMENT OUTCOME; WOUND HEALING;

ANTI-INFLAMMATORY AGENTS; COMBINED MODALITY THERAPY; FILTERING SURGERY; GLAUCOMA; HUMANS; TRIAMCINOLONE ACETONIDE; WOUND HEALING;

EID: 33845323680     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.04.075     Document Type: Article

References (17)

1. Quigley H.A., and Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90 (2006) 262-267
2. Feiner L., and Piltz-Seymour J.R. Collaborative initial glaucoma treatment study: a summary of results to date. Curr Opin Ophthalmol 14 (2003) 106-111
3. Lichter P.R., Musch D.C., Gillespie B.W., Guire K.E., Janz N.K., Wren P.A., et al. Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmol 108 (2001) 1943-1953
4. Lama P.J., and Fechtner R.D. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol 48 (2003) 314-346
5. Yoon P.S., and Singh K. Update on antifibrotic use in glaucoma surgery, including use in trabeculectomy and glaucoma drainage implants and combined cataract and glaucoma surgery. Curr Opin Ophthalmol 15 (2004) 141-146
6. Anand N., Arora S., and Clowes M. Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks. Br J Ophthalmol 90 (2006) 175-180
7. Lai W.W., Law R.W., and Lam D.S. Efficacy of periocular corticosteroid injections in the management of posterior uveitis. Clin Experiment Ophthalmol 33 (2005) 445-446
8. Broadway D.C., and Chang L.P. Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva. J Glaucoma 10 (2001) 237-249
9. Ebner R., Devoto M.H., Weil D., Bordaberry M., Mir C., Martinez H., et al. Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone. Br J Ophthalmol 88 (2004) 1380-1386
10. Schwartz K., and Budenz D. Current management of glaucoma. Curr Opin Ophthalmol 15 (2004) 119-126
11. Skuta G.L., and Parrish R.K. Wound healing in glaucoma filtering surgery. Surv Ophthalmol 32 (1987) 149-170
12. Sturmer J., Broadway D.C., and Hitchings R.A. Young patient trabeculectomy. Assessment of risk factors for failure. Ophthalmol 100 (1993) 928-939
13. Chen P.P., Yamamoto T., Sawada A., Parrish R.K., and Kitazawa Y. Use of antifibrosis agents and glaucoma drainage devices in the American and Japanese Glaucoma Societies. J Glaucoma 6 (1997) 192-196
14. Starita R.J., Fellman R.L., Spaeth G.L., Poryzees E.M., Greenidge K.C., and Traverso C.E. Short- and long-term effects of postoperative corticosteroids on trabeculectomy. Ophthalmol 92 (1985) 938-946
15. Araujo S.V., Spaeth G.L., Roth S.M., and Starita R.J. A ten-year follow-up on a prospective, randomized trial of postoperative corticosteroids after trabeculectomy. Ophthalmol 102 (1995) 1753-1759
16. Roth S.M., Spaeth G.L., Starita R.J., Birbillis E.M., and Steinmann W.C. The effects of postoperative corticosteroids on trabeculectomy and the clinical course of glaucoma: five-year follow-up study. Ophthalmic Surg 22 (1991) 724-729
17. Atreides S.P., Skuta G.L., and Reynolds A.C. Wound healing modulation in glaucoma filtering surgery. Int Ophthalmol Clin 44 (2004) 61-106